Genetic testing lowers risk of nevirapine skin rash
Kidney problems linked to tenofovir use, improve with switch to abacavir
Studies look at bone changes during second-line therapy, fractures, and HIV- and HCV-related bone loss
Genetics make a large contribution to cardiovascular risk for people with HIV
Almost three-quarters of people starting HIV therapy in Tanzania have dyslipidemia after three years of treatment
Dual CCR5/CCR2 inhibitor cenicriviroc has anti-inflammatory as well as anti-HIV effect
Small risk of neurological birth defects due to efavirenz confirmed in French cohort
